• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.

作者信息

Shafer R W, Winters M A, Jellinger R M, Merigan T C

出版信息

J Infect Dis. 1996 Aug;174(2):448-9. doi: 10.1093/infdis/174.2.448.

DOI:10.1093/infdis/174.2.448
PMID:8699089
Abstract
摘要

相似文献

1
Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.去羟肌苷单药治疗期间齐多夫定耐药逆转录酶突变
J Infect Dis. 1996 Aug;174(2):448-9. doi: 10.1093/infdis/174.2.448.
2
Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy.齐多夫定和/或多药耐药突变的HIV-1分离株在去羟肌苷-司他夫定联合治疗后的表型耐药模式。
J Acquir Immune Defic Syndr. 2000 Dec 15;25(5):465-6. doi: 10.1097/00042560-200012150-00014.
3
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.由联合抗逆转录病毒疗法导致的耐多药1型人类免疫缺陷病毒毒株。
J Virol. 1996 Feb;70(2):1086-90. doi: 10.1128/JVI.70.2.1086-1090.1996.
4
Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.从齐多夫定治疗转换为去羟肌苷治疗后患者体内HIV-1分离株的基因型演变
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):330-4.
5
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine.接受去羟肌苷和地拉韦啶联合治疗的患者的HIV-1药物敏感性及逆转录酶突变
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):136-44. doi: 10.1097/00042560-199702010-00006.
6
Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine.
AIDS. 2001 Apr 13;15(6):799-800. doi: 10.1097/00002030-200104130-00017.
7
Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team.
J Infect Dis. 1995 Jul;172(1):70-8. doi: 10.1093/infdis/172.1.70.
8
Detection of resistant mutations in the reverse transcriptase of HIV-1-infected children.检测HIV-1感染儿童逆转录酶中的耐药突变。
Clin Microbiol Infect. 2000 May;6(5):268-70. doi: 10.1046/j.1469-0691.2000.00058-1.x.
9
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.
Ann Intern Med. 1994 Aug 15;121(4):263-8. doi: 10.7326/0003-4819-121-4-199408150-00005.
10
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.从接受去羟肌苷和司他夫定治疗的个体中分离出的HIV-1毒株的表型和基因型耐药模式。
AIDS. 2000 Jan 28;14(2):F9-15. doi: 10.1097/00002030-200001280-00002.

引用本文的文献

1
Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.接受双脱氧肌苷单药治疗1至2年的感染个体中1型人类免疫缺陷病毒逆转录酶基因型和药物敏感性的变化
Antimicrob Agents Chemother. 1997 Apr;41(4):757-62. doi: 10.1128/AAC.41.4.757.